These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23210435)

  • 21. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
    Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
    J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis.
    Hayashi H; Kobara M; Abe M; Tanaka N; Gouda E; Toba H; Yamada H; Tatsumi T; Nakata T; Matsubara H
    Hypertens Res; 2008 Feb; 31(2):363-75. PubMed ID: 18360057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
    Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
    Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of paeoniflorin on irradiation-induced cell damage involved in modulation of reactive oxygen species and the mitogen-activated protein kinases.
    Li CR; Zhou Z; Zhu D; Sun YN; Dai JM; Wang SQ
    Int J Biochem Cell Biol; 2007; 39(2):426-38. PubMed ID: 17097910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice.
    Thandavarayan RA; Watanabe K; Sari FR; Ma M; Lakshmanan AP; Giridharan VV; Gurusamy N; Nishida H; Konishi T; Zhang S; Muslin AJ; Kodama M; Aizawa Y
    Free Radic Biol Med; 2010 Nov; 49(9):1422-31. PubMed ID: 20705132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paeoniflorin inhibits doxorubicin-induced cardiomyocyte apoptosis by downregulating microRNA-1 expression.
    Li JZ; Tang XN; Li TT; Liu LJ; Yu SY; Zhou GY; Shao QR; Sun HP; Wu C; Yang Y
    Exp Ther Med; 2016 Jun; 11(6):2407-2412. PubMed ID: 27284328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: Role of NOX4.
    Cheng G; Lanza-Jacoby S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):41-6. PubMed ID: 26225747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells.
    Simon F; Fernández R
    J Hypertens; 2009 Jun; 27(6):1202-16. PubMed ID: 19307985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis.
    Gilleron M; Marechal X; Montaigne D; Franczak J; Neviere R; Lancel S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):727-31. PubMed ID: 19699179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of valsartan administration on doxorubicin‑induced myocardial injury in rats and the role of oxidative stress and NOX2/NOX4 signaling.
    Cheng D; Chen L; Tu W; Wang H; Wang Q; Meng L; Li Z; Yu Q
    Mol Med Rep; 2020 Nov; 22(5):4151-4162. PubMed ID: 33000246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PROTECTIVE EFFECT OF LACTUCA SERRIOLA ON DOXORUBICIN-INDUCED TOXICITY IN H9C2 CELLS.
    Hosseini A; Mahdian D
    Acta Pol Pharm; 2016; 73(3):659-66. PubMed ID: 27476284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species.
    Hosseinzadeh L; Behravan J; Mosaffa F; Bahrami G; Bahrami A; Karimi G
    Food Chem Toxicol; 2011 May; 49(5):1102-9. PubMed ID: 21295102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
    Kim KH; Oudit GY; Backx PH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of paeoniflorin against corticosterone-induced neurotoxicity in PC12 cells.
    Mao QQ; Zhong XM; Qiu FM; Li ZY; Huang Z
    Phytother Res; 2012 Jul; 26(7):969-73. PubMed ID: 22131171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relevant study on apoptosis of cervical cancer HeLa cells induced by paeoniflorin].
    Zhang LL; Zhang SL; Wang SZ
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(47):3371-5. PubMed ID: 21223758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes.
    Han X; Pan J; Ren D; Cheng Y; Fan P; Lou H
    Food Chem Toxicol; 2008 Sep; 46(9):3140-6. PubMed ID: 18652870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protective effect of paeoniflorin on Abeta25-35 -induced PC12 cell injury].
    Wang S; Liu L
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2448-51. PubMed ID: 23234147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.
    Kim DS; Kim HR; Woo ER; Kwon DY; Kim MS; Chae SW; Chae HJ
    Eur J Pharmacol; 2006 Jul; 541(1-2):24-32. PubMed ID: 16780832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of paeoniflorin on lysophosphatidylcholine-induced inflammatory factor production in human umbilical vein endothelial cells.
    Li JZ; Wu JH; Yu SY; Shao QR; Dong XM
    Int J Mol Med; 2013 Feb; 31(2):493-7. PubMed ID: 23241947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
    McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
    Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.